Search

The article discusses the nature, causes and symptoms of osteoporosis, a disease of the skeleton in which bones become brittle and prone to fracture. Osteoporosis can either be primary or secondary depending on its occurrence. Causes of the disease include genetic factors, alcoholism, corticosteroids and chemicals. Common symptoms of the disorder include fracture of a vertebra, pain, disfigurement and debilitation.

The article presents information related to osteoporosis. Osteoporosis is a disease of the skeleton in which bones become brittle and prone to fracture. In other words, the bone loses density. Osteoporosis is diagnosed when bone density has decreased to the point where fractures occur with mild stress. There are two primary kinds of osteoporosis: type I and type II. The determining factor for the actual existence of osteoporosis, whether type I or type II, is the amount of calcium left in the skeleton and whether it places a person at risk for fracture.

The article offers information related to the discovery of new therapies for depression. Wyeth Pharmaceuticals has obtained a conditional approval from the U.S. Food and Drug Administration for the trials of the depression drug, Pristiq, for the treatment of adult patients having major depressive disorder. Researchers from McGill University founds that the use of antidepressants in adults has been linked to a risk of fractures resulting from fall.

A review of the articles such as "The Complexities of Elder Abuse," by Karen A. Roberto, in the April 2016 issue of the journal "American Psychologist" and "Is This Broken Bone Because of Abuse? Characteristics and Comorbid Diagnoses in Older Adults With Fractures," by Melanie W. Gironda, Annie L. Nguyen, & Laura M. Mosqueda, in the August issue of the "Journal of the American Geriatrics Society," are presented.

Focuses on the socioeconomic evaluation of osteoporosis. Determination of the burden of the disease; Pharmacoeconomic evaluation; Evaluation of medical costs; Evaluation of screening programs; Morbidity associated with different osteoporotic fractures.

Discusses diagnostic methods for osteoporosis. Methods of measuring bone mass and density; Assessment of fracture risk; Risk factors for osteoporosis.

Discusses the epidemiology and risk factors of osteoporosis. Incidence and prevalence of fractures related to osteoporosis; Use of bone mass as a determinant of bone strength and propensity; Drugs associated with an increased risk of osteoporosis.

Discusses the pathophysiology of osteoporosis and osteoporosis-related fractures. Normal characteristics of bone; Importance of calcium in the bone; Determinants of osteoporotic fractures.

Remember the saying, "Sticks and stones can break my bones, but words can never hurt me?" "Keep your conversations with consumers real", she says, but understand that our lingo might confuse or even frighten consumers. [Extracted from the article]

Reports that the European Union's Committee for Proprietary Medicinal Products has issued a positive opinion for the use of Roche's Bondronat in the prevention of skeletal events, such as pathological fractures, bone complications requiring radiotherapy or surgery, in patients with breast cancer and bone metastases.